Leveraging Data with Model-Informed Drug Development (MIDD) for Optimal Study Design and Analysis | Allucent

Model-Informed Drug Development

Model-Informed Drug Development Hero

Let your data be your guide. With model-informed drug development (MIDD), you can leverage your existing data and others to optimize your pre-clinical and clinical studies and development programs. Allucent has an expert team of pharmacometricians and modelers with state-of-the-art high-performance computing (AWS) to help you design, simulate and analyze your drug development studies and programs.

Download the full case study below to learn more.

Request a Proposal

Allucent is committed to protecting and respecting your privacy. By submitting your information to us via this website your business details will be added to our database. For information on our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Notice. For general information on how Allucent processes personal data, please see our Privacy Policy.

Featured Content

Partner With the A-Team

Let us know how we can help you bring new therapies to light. Get in touch to get started.

Join the A-Team

Want to help small and mid-sized biotech companies change the therapeutic landscape?

Subscribe to our monthly newsletter